Perovskite materials: Neutrons show twinning in halide perovskites
Dr. Michael Tovar working at FALCON at the neutron Source BER II. © HZB
The Laue camera captured the diffraction pattern. © HZB
Solar cells based on hybrid halide perovskites achieve high efficiencies. These mixed organic-inorganic semiconductors are usually produced as thin films of microcrystals. An investigation with the Laue camera at the neutron source BER II could now clarify that twinning occurs during crystallisation even at room temperature. This insight is helpful for optimising production processes of halide perovskites.
A good ten years ago, research teams discovered the class of semi-organic halide perovskites, which are now making a rapid career as new materials for solar cells. The mixed organic-inorganic semiconductors achieved efficiencies of over 25 percent within a few years. They take their name from their basic structure, which is very similar to that of the mineral perovskite (CaTiO3), but contains other components: halide anions, lead cations and organic molecular cations.
MAPI examined
In the case of the most important compound of the class, methylammonium lead iodide CH3NH3PbI3 (usually abbreviated as MAPI), which was also studied here, the molecular cations are methylammonium cations and the anions are iodide anions. Although more than 4000 publications on halide perovskites have appeared in 2019 alone, it has not yet been possible to fully understand their structure. In the case of MAPI this was attributed, among other things, to the fact that they are produced as polycrystalline films at elevated temperature and it was assumed that twinning occurs when they are cooled to room temperature.
Close examination with neutrons
The formation of twins is complex and can significantly change the material properties. It is therefore exciting to investigate this process more closely. "We have now crystallised MAPI at room temperature and analysed the crystals thus formed with the Laue camera Falcon on BER II," says Dr. Joachim Breternitz, HZB. Together with his colleagues Prof. Susan Schorr and Dr. Michael Tovar, he was able to determine from the data that crystals grown at room temperature also form twins. This gives a new insight into the crystallization and growth process of MAPI. "Our results indicate that the crystallisation nuclei have a higher symmetry than the bulk crystals," explains Breternitz.
With these insights, the synthesis of the technologically important thin films can be specifically optimised.
The neutron source BER II has provided neutrons for research until its scheduled shutdown in December 2019. "This was one of our last experiments at FALCON on BER II and I hope that we were able to make useful contributions right up to the end," says Breternitz.
- Catalysis research at HZB gets new facilityAs part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.